Caldera Therapeutics granted exclusive worldwide rights to develop, commercialize Qyuns Therapeutics product candidates

Caldera Therapeutics has been granted exclusive worldwide rights to develop and commercialize product candidates from Qyuns Therapeutics.

Detected & updated continuously · Source: Nebula

Story subjects

Caldera TherapeuticsQyuns Therapeutics

Track sentiment and mindshare across stocks and crypto in Nebula.

Open Nebula